Class IV devices are considered highest-risk medical devices under the Medical Device Administrative Control System (MDACS) in Hong Kong. While MDACS is voluntary, listing is required for participation in public hospital tenders and is often seen as a mark of compliance with international safety and performance standards.
A Hong Kong-based entity or individual must be appointed as the LRP.
The LRP is the official liaison with the Medical Device Division (MDD) and is responsible for:
Submitting the application
Holding technical documentation
Handling post-market surveillance and incident reporting
Must register with MDD using Form MD1 before submitting device applications.
The device must be approved or authorized in at least one of the following "Reference Countries":
European Union (CE marking under MDR)
United States (FDA 510(k) or PMA)
Australia (TGA listing)
Canada (Health Canada MDL)
Japan (PMDA or MHLW approval)
You must submit:
Valid approval certificate(s)
Declaration of conformity to applicable standards
Copy of labeling and Instructions for Use (IFU)
The device must have complete technical documentation covering:
| Requirement | Description |
|---|---|
| Device Description | Details of intended use, design, and performance |
| Risk Analysis | Risk management file (in accordance with ISO 14971) |
| Clinical Evaluation | Summary of clinical data or equivalent evidence (per MEDDEV 2.7/1 rev. 4 or MDR) |
| Instructions for Use (IFU) | In English or Chinese, compliant with labeling requirements |
| Post-market Surveillance Plan | Procedures for ongoing safety monitoring |
| Quality System Certificate | Preferably ISO 13485 for the manufacturing site(s) |
| Manufacturer's Declaration | Declaration that the device complies with applicable safety and performance standards |
You must submit:
Form MD4 (Application for listing Class II/III/IV device)
LRP’s business registration certificate
Letter of authorization from the manufacturer to the LRP
Product brochures and photos of the device and packaging
Labels must be in English or Chinese (or both)
Must include:
Device name
Model/Reference number
Manufacturer’s name and address
Instructions for use (IFU)
Batch/serial number
Expiry date (if applicable)
Warnings/precautions
There is currently no application fee for device listing under the voluntary MDACS program.
Once listed, the LRP must:
Report adverse events or incidents to MDD
Manage product recalls or safety actions
Update MDD if:
There are significant changes to the device
New approvals or withdrawals happen in reference countries
| Requirement | Mandatory? |
|---|---|
| Local Responsible Person (LRP) | ✅ Yes |
| Reference Country Approval | ✅ Yes |
| Technical Documentation | ✅ Yes |
| Clinical Evaluation Report | ✅ Yes |
| Risk Management File | ✅ Yes |
| IFU and Labeling | ✅ Yes |
| Manufacturer’s Declaration | ✅ Yes |
| ISO 13485 QMS Certificate | ✅ Strongly recommended |
| Application Form (MD4) | ✅ Yes |
| Letter of Authorization | ✅ Yes |
| Post-market Surveillance Plan | ✅ Yes |

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn